These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8065779)

  • 1. Governmental antitrust policy: soon obsolete?
    Uzych L
    Pa Med; 1994 Jun; 97(6):26-7. PubMed ID: 8065779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives. Antitrust enforcement: reshaping the health system.
    Kent C
    Faulkner Grays Med Health; 1994 Dec; 48(48):suppl 1-4. PubMed ID: 10138740
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitrust enforcement guidelines for providers in the wake of health care reform.
    Zoric S
    J Health Hosp Law; 1993 Dec; 26(12):359-64, 358. PubMed ID: 10138597
    [No Abstract]   [Full Text] [Related]  

  • 4. Revised antitrust guidelines. Forming physician network joint ventures.
    Anderson KR
    Physician Exec; 1997 Feb; 23(2):24-6. PubMed ID: 10164971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint antitrust enforcement policy: a first step, but questions remain.
    Kopit WG
    Physician Exec; 1994 Jan; 20(1):41-2. PubMed ID: 10132127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitrust: stage 1 of health reform.
    Leech JD
    Trustee; 1993 Dec; 46(12):16-7. PubMed ID: 10130690
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinton administration's new antitrust guidelines duck many important issues.
    Sneed JH; Marx D
    Healthspan; 1993 Nov; 10(10):25-9. PubMed ID: 10130837
    [No Abstract]   [Full Text] [Related]  

  • 8. Insights for hospitals: the 1994 health care antitrust enforcement policy statements.
    Marx D; Busey RC
    J Health Hosp Law; 1995; 28(3):143-50. PubMed ID: 10155907
    [No Abstract]   [Full Text] [Related]  

  • 9. Health care joint ventures and the antitrust laws: a guardedly optimistic prognosis.
    Gotts IK
    J Contemp Health Law Policy; 1994; 10():169-93. PubMed ID: 10134809
    [No Abstract]   [Full Text] [Related]  

  • 10. Revised DOJ and FTC policy statements offer more options for physician joint ventures.
    Busey RC
    Healthc Financ Manage; 1996 Nov; 50(11):79-80, 82. PubMed ID: 10162353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New antitrust enforcement policy statements issued for health care providers.
    Enders RJ
    Health Care Law Newsl; 1994 Dec; 9(12):3-8. PubMed ID: 10154604
    [No Abstract]   [Full Text] [Related]  

  • 12. Interpreting the 1996 federal antitrust guidelines for physician joint venture networks.
    Hirshfeld E
    Ann Health Law; 1997; 6():1-49. PubMed ID: 10173274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not so fast. Doctors and hospitals are running head-on into federal antitrust laws.
    Serafini MW
    Natl J (Wash); 1994 Dec; 26(51-52):2967-70. PubMed ID: 10139127
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated delivery systems: reforming the conflicts among federal referral, tax exemption, and antitrust laws.
    Woodhall AL
    Health Matrix Clevel; 1995; 5(1):181-248. PubMed ID: 10141744
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitrust exemption: are health providers crying wolf?
    Barnett AA
    J Am Health Policy; 1993; 3(3):38-41. PubMed ID: 10125734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiology turf wars and antitrust law.
    Colonna TE; Thomas D
    Tex Med; 2000 Aug; 96(8):64-8. PubMed ID: 10948840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitrust implications of health care reform.
    Dempsey J; Schmidt W
    Health Care Superv; 1995 Sep; 14(1):14-8. PubMed ID: 10144613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How providers can preserve mutually beneficial joint ventures.
    Hoffman SW; Olson CE; Shirilla PM
    Health Care Strateg Manage; 1992 Sep; 10(9):7-9. PubMed ID: 10121307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserving antitrust.
    O'Neil-White A; Wilber K
    HMO; 1995; 36(3):15-7. PubMed ID: 10166472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converting new antitrust guidance into action.
    Johnson BA
    Med Group Manage J; 1997; 44(1):22-6, 62. PubMed ID: 10164264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.